Hypoxia Inducible Factor 1 Alpha as a Novel Biomarker in Septic Shock

CompletedOBSERVATIONAL
Enrollment

63

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Sepsis
Interventions
PROCEDURE

Septic patients

The investigators will draw two sets of blood samples. One at baseline, 10 mL, and another, 24 hours later, 10 mL, for a total of 20 mL.

PROCEDURE

Healthy Control

The investigators will draw 10 mL, once, during baseline for a total of 10 mL among the healthy control group.

Trial Locations (1)

32610

University of Florida, Gainesville

All Listed Sponsors
lead

University of Florida

OTHER

NCT02163473 - Hypoxia Inducible Factor 1 Alpha as a Novel Biomarker in Septic Shock | Biotech Hunter | Biotech Hunter